Thermal Ablation for Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma

Area of Science:

• Endocrinology
• Minimally Invasive Surgery
• Oncology

Background:

• Large, hypoenhancing benign thyroid nodules can cause compression or cosmetic issues.
• Minimally invasive thermoablative (MIT) therapies present a therapeutic alternative for specific patient groups.
• Current options include surgery, but MIT offers a less invasive approach.

Purpose of the Study:

• To evaluate the efficacy and safety of ultrasound-guided MIT for benign thyroid nodules.
• To explore the potential of MIT, specifically laser-based treatments (TAL), for papillary microcarcinoma.
• To position MIT as a complementary or alternative treatment to surgery.

Main Methods:

• Ultrasound-guided minimally invasive thermoablative (MIT) procedures.
• Thermal necrosis induction for nodule ablation.
• Evaluation of nodule size reduction, functional consequences, and complication rates.

Main Results:

• MIT achieves a 50% reduction in nodule size without functional consequences.
• The procedure is well-tolerated, safe, non-invasive, and requires no general anesthesia.
• Complications are rare and transient, with laser ablation (TAL) showing promise for microcarcinoma.

Conclusions:

• Ultrasound-guided MIT is a viable, safe, and effective option for selected benign thyroid nodules.
• MIT complements rather than replaces traditional surgery and requires specialized expertise.
• Further research is needed to fully understand the efficacy and safety of MIT for papillary microcarcinoma.